A Decade of Marketing Authorization Applications of Anticancer Drugs in the European Union: An Analysis of Procedural Timelines

BACKGROUND: Cancer is a serious global health problem and a major cause of death. The European Medicines Agency (EMA) has established several regulatory initiatives to expedite the development and authorization of drugs to ensure timely access of patients. In this study, we analyzed the procedural t...

Descripción completa

Detalles Bibliográficos
Autores principales: Garsen, Marjolein, Steenhof, Maaike, Zwiers, Alex
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238922/
https://www.ncbi.nlm.nih.gov/pubmed/33543409
http://dx.doi.org/10.1007/s43441-021-00260-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238922/
https://www.ncbi.nlm.nih.gov/pubmed/33543409
http://dx.doi.org/10.1007/s43441-021-00260-5

Ejemplares similares